TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25502058

Group type: EXPERIMENTAL
Intervention: Self-management intervention (learning catheter-related self-monitoring and self-management skills during home visits by a study nurse)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 202
Study: 22677357

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg daily for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 20
Study: 21718165

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg twice a day (b.i.d) starting 24 h prior to ascent
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 24
Study: 19339719

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 131746

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 131746

Group type: EXPERIMENTAL
Intervention: Cytologic testing
Number of subjects: 131746

Group type: EXPERIMENTAL
Intervention: VIA
Number of subjects: 131746
Study: 16126411

Group type: EXPERIMENTAL
Intervention: Elastic compressive stockings (ECS) applied during voluntary contractions
Number of subjects: 9

Group type: COMPARATOR
Intervention: No elastic compressive stockings (ECS) applied during voluntary contractions
Number of subjects: 9
Study: 15331681

Group type: EXPERIMENTAL
Intervention: Exercise countermeasure (CM-gr)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (Co-gr)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intolerant subjects
Number of subjects: 18
Study: 11784476

Group type: COMPARATOR
Intervention: Ethanol 0 g/kg (placebo)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ethanol 0.35 g/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ethanol 0.7 g/kg
Number of subjects: 16

Group type: COMPARATOR
Intervention: N(2)O 0% (100% O(2), placebo)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: N(2)O 30% (in O(2))
Number of subjects: 16
Study: 9808223

Group type: EXPERIMENTAL
Intervention: Retinol-rich food (556 retinol equivalents (RE)/d)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Fruit (509 RE/d)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Dark-green, leafy vegetables and carrots (684 RE/d)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Low-retinol, low-carotene food (44 RE/d)
Number of subjects: 238
Study: 8034835

Group type: EXPERIMENTAL
Intervention: Relapse Prevention (RP) intervention
Number of subjects: 212

Group type: COMPARATOR
Intervention: Social Support (SSP) group discussion intervention
Number of subjects: 212
Study: 2661989

Group type: EXPERIMENTAL
Intervention: Ambroxol (30 mg, 2 sachets daily for 10 days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Acetylcysteine (200-300 mg, 2-3 sachets daily for 10 days)
Number of subjects: 28
Study: 29693035

Group type: EXPERIMENTAL
Intervention: Massage therapy for 10-15 min, three times a week for 10 sessions
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 50
Study: 27440192

Group type: EXPERIMENTAL
Intervention: 12 week supervised exercise therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 140
Study: 24913266

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 5706
Study: 22484700

Group type: EXPERIMENTAL
Intervention: hilafilcon B silicone hydrogel contact lenses for 8 h
Number of subjects: 15

Group type: COMPARATOR
Intervention: narafilcon A silicone hydrogel contact lenses for 8 h
Number of subjects: 15
Study: 19935409

Group type: EXPERIMENTAL
Intervention: Pregabalin treatment
Number of subjects: 30
Study: 18492000

Group type: EXPERIMENTAL
Intervention: Postural exercises for 10 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Strength and fitness exercises for 10 weeks
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 88
Study: 15711607

Group type: EXPERIMENTAL
Intervention: Bicalutamide 50 mg o.d.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cyproterone acetate 100 mg t.i.d.
Number of subjects: 40
Study: 12680736

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg/70 kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: d-Amphetamine (20 mg/70 kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg/70 kg) and d-Amphetamine (20 mg/70 kg) conjointly
Number of subjects: 20
Study: 10505587

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg orally)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2676253

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 330291

Group type: EXPERIMENTAL
Intervention: Lomotil
Number of subjects: 83

Group type: COMPARATOR
Intervention: Imodium
Number of subjects: 83
Study: 30508780

Group type: EXPERIMENTAL
Intervention: Older children
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Less physical activity
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Shorter nap(s)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Later wake‐up times
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Late bedtimes
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: None of the potential correlates
Number of subjects: 173
Study: 28185300

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training 2.5 times per week for 3 months
Number of subjects: 41
Study: 26367862

Group type: EXPERIMENTAL
Intervention: Yoga strengthening program (12 weeks, 3 sessions per week)
Number of subjects: 38
Study: 24180235

Group type: EXPERIMENTAL
Intervention: Ma Zi Ren Wan and western medicine placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Senna and Chinese medicine placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chinese medicine placebo and western medicine placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 21518647

Group type: EXPERIMENTAL
Intervention: Medihoney Antibacterial Medical Honey (2 mL of a 50/50 mixture of honey-saline solution once a day at night for 30 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Medihoney Antibacterial Medical Honey
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control nostrils (no honey treatment)
Number of subjects: 34
Study: 19143666

Group type: EXPERIMENTAL
Intervention: High-threshold group (phototherapy interrupted when TSB decreased to >/=1 mg/dL below limit)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Low-threshold group (phototherapy interrupted when TSB decreased to >/=3 mg/dL below limit)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Presence of haemolysis or G6PD deficiency
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Absence of haemolysis or G6PD deficiency
Number of subjects: 52
Study: 17532415

Group type: COMPARATOR
Intervention: Vehicle (n = 9)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: ET-A receptor antagonist 2 mg/kg (n = 8)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: All treatment groups (n = 44)
Number of subjects: 44
Study: 15200755

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg plus lovastatin 20 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg plus lovastatin 40 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Lovastatin 20 mg alone
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 11207020

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg b.i.d.
Number of subjects: 259

Group type: COMPARATOR
Intervention: On-demand salbutamol (ODS)
Number of subjects: 259
Study: 9765761

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 0
Study: 7976095

Group type: EXPERIMENTAL
Intervention: Surgery for incompetent perforators
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Surgery for incompetent perforators and ulcer excision followed by grafting
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (conservative treatment)
Number of subjects: 47
Study: 3055325

Group type: EXPERIMENTAL
Intervention: Disulfiram administration (Group 1)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Disulfiram administration (Group 2)
Number of subjects: 14
Study: 381616

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30868622

Group type: EXPERIMENTAL
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Collagen Matrix (CMX)
Number of subjects: 155
Study: 28153654

Group type: EXPERIMENTAL
Intervention: Intravenous dextrose 5% with normal saline
Number of subjects: 193

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 193
Study: 25880166

Group type: EXPERIMENTAL
Intervention: mexiletine (600 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 23321403

Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine combination (20/5 mg)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Amlodipine (10 mg)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Olmesartan (20 mg)
Number of subjects: 276
Study: 22967781

Group type: EXPERIMENTAL
Intervention: Long-term return to work (RTW)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Long-term symptom remission
Number of subjects: 117
Study: 20196699

Group type: EXPERIMENTAL
Intervention: Corrective feedback (CF)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Dual-screen guidance (DSG)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both instructional conditions (CF and DSG)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 7-year-olds
Number of subjects: 21
Study: 18050202

Group type: EXPERIMENTAL
Intervention: Diacerein
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 16091994

Group type: EXPERIMENTAL
Intervention: 0.25% w/v Avicel CL611
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2% w/v methylcellulose (MC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breathing rate of 10 L/min
Number of subjects: 0
Study: 12173800

Group type: EXPERIMENTAL
Intervention: Aerosolized ceftazidime 250 mg every 12 hours for up to 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aerosolized ceftazidime
Number of subjects: 40
Study: 10463708

Group type: EXPERIMENTAL
Intervention: Audiobooklet (AB) decision aid
Number of subjects: 287

Group type: COMPARATOR
Intervention: Usual care alone (control group)
Number of subjects: 287
Study: 7614501

Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0
Study: 2203252

Group type: EXPERIMENTAL
Intervention: 5 g FO, supplying 2 g n-3 fatty acids
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 20 g FO, supplying 8 g n-3 fatty acids
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (0 g FO)
Number of subjects: 15
Study: 379993

Group type: EXPERIMENTAL
Intervention: Alprenolol
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 30991987

Group type: EXPERIMENTAL
Intervention: Personalised risk information in numeric form (e.g. 1 in 100) with use of infographics
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Personalised information described as 'highest', 'moderate' or 'lowest' risk with use of infographics
Number of subjects: 30

Group type: COMPARATOR
Intervention: Positive test result, as is current practice
Number of subjects: 30
Study: 29267553

Group type: EXPERIMENTAL
Intervention: Symbiotics (Lactobacillus acidophilus 108 to 109 CFU, Lactobacillus rhamnosus 108 to 109 CFU, Lactobacillus casei 108 to 109 CFU, Bifidobacterium 108 to 109 CFU, fructo‐oligosaccharide (FOS) 6g)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Symbiotics
Number of subjects: 91
Study: 25985386

Group type: COMPARATOR
Intervention: Sigh at 0.5/min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sigh
Number of subjects: 20
Study: 23442831

Group type: EXPERIMENTAL
Intervention: Premedication with pronase, dimethylpolysiloxane, and sodium bicarbonate 10 to 30 minutes before UGI endoscopy (Group B)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Premedication with pronase, dimethylpolysiloxane, and sodium bicarbonate 10 minutes before UGI endoscopy (Group A)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Premedication with pronase, dimethylpolysiloxane, and sodium bicarbonate 30 minutes before UGI endoscopy (Group C)
Number of subjects: 300
Study: 21452030

Group type: EXPERIMENTAL
Intervention: HPV vaccine radionovela
Number of subjects: 88
Study: 19176275

Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioral Therapy (CBT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Enhanced Supportive Therapy (ST)
Number of subjects: 65
Study: 17101746

Group type: EXPERIMENTAL
Intervention: Modified-release zolpidem (12.5 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Immediate-release zolpidem (10 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 15233714

Group type: EXPERIMENTAL
Intervention: Conflict-oriented in-patient therapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Systemic out-patient therapy
Number of subjects: 80
Study: 11414004

Group type: EXPERIMENTAL
Intervention: Training on the blind positioning task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Changing the hand used in the task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Changing the location of the stick
Number of subjects: 0

Group type: COMPARATOR
Intervention: Changing both hand and location
Number of subjects: 0
Study: 9406884

Group type: EXPERIMENTAL
Intervention: Evoked gamma activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induced gamma activity (single trial analysis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induced activity for non-target trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induced activity for target responses
Number of subjects: 0
Study: 8216413

Group type: COMPARATOR
Intervention: Acetaminophen (ACT)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Naproxen (NPX)
Number of subjects: 178
Study: 3113339

Group type: COMPARATOR
Intervention: Conventional-dose group: 600 mg of tegafur p.o. daily and 1-2 mg of lentinan i.v. weekly
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-dose group: 1200-800 mg of tegafur p.o. daily and 4 mg of lentinan i.v. weekly
Number of subjects: 34
Study: 28948980

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (30 mg) before extinction training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo before extinction training
Number of subjects: 40
Study: 27721049

Group type: EXPERIMENTAL
Intervention: Jasmine rice panicle extract (0.1-0.2%)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Jasmine rice panicle extract (0.1% and 0.2%)
Number of subjects: 24
Study: 24622044

Group type: EXPERIMENTAL
Intervention: Intervention households from the IHIP trial
Number of subjects: 892

Group type: COMPARATOR
Intervention: Control households from the IHIP trial
Number of subjects: 892
Study: 24052035

Group type: EXPERIMENTAL
Intervention: Moderate-dose endurance exercise (MOD: ≈ 30 min/day)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High-dose endurance exercise (HIGH: ≈ 60 min/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 64
Study: 20973459

Group type: EXPERIMENTAL
Intervention: High-calcium fortified milk (400 ml daily for 16 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 60
Study: 18097225

Group type: EXPERIMENTAL
Intervention: NRTI-containing regimen (zidovudine/lamivudine)
Number of subjects: 20

Group type: COMPARATOR
Intervention: NRTI-sparing regimen (nevirapine)
Number of subjects: 20
Study: 16060208

Group type: EXPERIMENTAL
Intervention: Nutrition supplementation from 1969-77
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team approach
Number of subjects: 0
Study: 12123405

Group type: EXPERIMENTAL
Intervention: Early advance care planning (ACP) facilitated by a trained nurse facilitator
Number of subjects: 61
Study: 7674467

Group type: EXPERIMENTAL
Intervention: Protamine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 120
Study: 2048623

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention related to leisure activities
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 7316528

Group type: EXPERIMENTAL
Intervention: 0.1% anthralin
Number of subjects: 14

Group type: COMPARATOR
Intervention: 0.05% anthralin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vehicle alone
Number of subjects: 14
Study: 31531365

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (EG)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No therapeutic intervention (CG)
Number of subjects: 49
Study: 28977347

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (150 kcal, 20 g whey protein, 800 IU vitamin D, 119 mL beverage)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo (30 kcal, nonnutritive, 119 mL)
Number of subjects: 149
Study: 26501267

Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs (600 mg EPA and 625 mg DHA per day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 76
Study: 25124011

Group type: EXPERIMENTAL
Intervention: Robot-assisted remote echocardiography and teleconsultation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard of care consultation
Number of subjects: 19
Study: 22691248

Group type: EXPERIMENTAL
Intervention: L. reuteri (108 CFU = 5 drops per day) for 60 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (5 drops per day) for 60 days
Number of subjects: 50
Study: 19799559

Group type: EXPERIMENTAL
Intervention: Novel neighboring sites model for methylation patterns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previously developed stochastic models for methylation change
Number of subjects: 0
Study: 16760200

Group type: EXPERIMENTAL
Intervention: Cardiac catheterization in elderly patients
Number of subjects: 1794

Group type: EXPERIMENTAL
Intervention: Cardiac catheterization in US cohort
Number of subjects: 1794

Group type: EXPERIMENTAL
Intervention: Cardiac catheterization in non-US cohort
Number of subjects: 1794

Group type: EXPERIMENTAL
Intervention: Revascularization in elderly who underwent catheterization in US cohort
Number of subjects: 1794

Group type: COMPARATOR
Intervention: 90-day rates of death and death or myocardial infarction (MI) in elderly who underwent catheterization
Number of subjects: 1794
Study: 12524069

Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg daily)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (50 mg) with ethinyl estradiol (EE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Observation (no treatment)
Number of subjects: 48
Study: 10501359

Group type: COMPARATOR
Intervention: Conventional spacer
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sealed 500 mL plastic bottle
Number of subjects: 88

Group type: COMPARATOR
Intervention: Unsealed 500 mL bottle
Number of subjects: 88

Group type: COMPARATOR
Intervention: 200 mL polystyrene cup
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Nebulised fenoterol (after initial treatment)
Number of subjects: 88
Study: 8927681

Group type: EXPERIMENTAL
Intervention: Olanzapine (two doses)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 1909692

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine A (5 mg/kg/day) for 12 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (0.05 ml/kg/day)
Number of subjects: 22
Study: 6366807

Group type: EXPERIMENTAL
Intervention: Dithranol cream 0.25%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dithranol cream 0.1%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dithranol ointment 0.25%
Number of subjects: 60
Study: 31593254

Group type: EXPERIMENTAL
Intervention: Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 29409778

Group type: EXPERIMENTAL
Intervention: TFOX regimen (docetaxel at 50 mg/m2)
Number of subjects: 506

Group type: COMPARATOR
Intervention: FOLFOX regimen (without docetaxel)
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: TFOX regimen
Number of subjects: 506

Group type: COMPARATOR
Intervention: FOLFOX regimen
Number of subjects: 506
Study: 26890969

Group type: EXPERIMENTAL
Intervention: Explosive and progressive heavy-resistance training (PRT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nontraining control (CON)
Number of subjects: 35
Study: 24726380

Group type: EXPERIMENTAL
Intervention: Experimental orthoses
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional orthoses
Number of subjects: 16
Study: 23127294

Group type: EXPERIMENTAL
Intervention: Presence of medical evidence for pain
Number of subjects: 102

Group type: COMPARATOR
Intervention: Absence of medical evidence for pain
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Presence of psychosocial influences
Number of subjects: 102

Group type: COMPARATOR
Intervention: Absence of psychosocial influences
Number of subjects: 102
Study: 20568440

Group type: EXPERIMENTAL
Intervention: Expertise-based randomized controlled trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional randomized controlled trial
Number of subjects: 0